Common Contracts
11 similar Employment Agreement contracts by Adagio Therapeutics, Inc.
EMPLOYMENT AGREEMENTEmployment Agreement • July 5th, 2022 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • Vermont
This Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and David Hering (the “Executive”), this 5h day of July, 2022. This Agreement supersedes in its entirety that certain Amended and Restated Employment Agreement, dated August 5, 2021, as amended on February 23, 2022 (the “Prior Agreement”), between the Executive and the Company.
Employment AGREEMENTEmployment Agreement • March 31st, 2022 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • New Jersey
This Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and Jill Andersen (the “Executive”), this 24th day of September 2021.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 21st, 2022 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • Vermont
This Amended and Restated Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and David Hering (the “Executive”), this 5th day of August, 2021. This Agreement amends, restates, and supersedes in its entirety that certain Employment Agreement, dated June 30, 2021 (the “Prior Agreement”), between the Executive and the Company.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 21st, 2022 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • Connecticut
This Amended and Restated Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and Jane Henderson (the “Executive”), this 5th day of August 2021. This Agreement amends, restates, and supersedes in its entirety that certain Employment Agreement, dated December 22, 2020 (the “Prior Agreement”), between the Executive and the Company.
EMPLOYMENT AGREEMENTEmployment Agreement • September 20th, 2021 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
This Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and Rebecca Dabora (the “Executive”), this 5th day of August, 2021. This Agreement supersedes in its entirety that certain Offer Letter, dated May 10, 2021 (the “Prior Agreement”), between the Executive and the Company.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • September 20th, 2021 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and Lynn Connolly (the “Executive”), this 5th day of August, 2021. This Agreement amends, restates, and supersedes in its entirety that certain Employment Agreement, dated November 9, 2020 (the “Prior Agreement”), between the Executive and the Company.
EMPLOYMENT AGREEMENTEmployment Agreement • August 4th, 2021 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • Vermont
This Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and Rebecca Dabora (the “Executive”), this 5th day of August, 2021. This Agreement supersedes in its entirety that certain Offer Letter, dated May 10, 2021 (the “Prior Agreement”), between the Executive and the Company.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 4th, 2021 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and Lynn Connolly (the “Executive”), this 5th day of August, 2021. This Agreement amends, restates, and supersedes in its entirety that certain Employment Agreement, dated November 9, 2020 (the “Prior Agreement”), between the Executive and the Company.
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • August 2nd, 2021 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • California
This Amended and Restated Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and Lynn Connolly (the “Executive”), this [___] day of [_______] 2021. This Agreement amends, restates, and supersedes in its entirety that certain Employment Agreement, dated November 9, 2020 (the “Prior Agreement”), between the Executive and the Company.
EMPLOYMENT AGREEMENTEmployment Agreement • August 2nd, 2021 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • New Hampshire
This Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and Tillman Gerngross (the “Executive”), this [___] day of [_______] 2021. This Agreement supersedes in its entirety that certain Consulting Agreement, dated June 19, 2020 (the “Prior Agreement”), between the Executive and the Company.
EMPLOYMENT AGREEMENTEmployment Agreement • August 2nd, 2021 • Adagio Therapeutics, Inc. • Biological products, (no disgnostic substances) • Vermont
This Employment Agreement (“Agreement”) is made between Adagio Therapeutics, Inc., a Delaware corporation (the “Company”), and Rebecca Dabora (the “Executive”), this [___] day of [_______] 2021. This Agreement supersedes in its entirety that certain Offer Letter, dated May 10, 2021 (the “Prior Agreement”), between the Executive and the Company.
